+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In vitro activity of fosfomycin trometamol against pathogens from urinary tract infections: a Spanish multicenter study



In vitro activity of fosfomycin trometamol against pathogens from urinary tract infections: a Spanish multicenter study



Journal of ChemoTherapy 9(6): 394-402



The in-vitro susceptibilities of a total of 1371 urinary tract pathogens to fosfomycin trometamol were determined. According to the NCCLS breakpoints, Enterobacteriaceae and gram-positive microorganisms were, in general, very sensitive to this antimicrobial. More than 90.0% of the Escherichia coli and Citrobacter spp. and more than 70.0% of the Klebsiella pneumoniae, K. oxytoca, Enterobacter spp., Proteus mirabilis, Staphylococcus aureus, coagulase-negative staphylococci and Enterococcus spp. strains tested were susceptible to fosfomycin trometamol. However, Pseudomonas aeruginosa and Acinetobacter spp. strains were more resistant. In general, recent clinical isolates from urinary tract infections (UTIs) in both community and hospital were also very sensitive (> 80.0%) to fosfomycin, its activity being higher than that of the rest of the antimicrobials commonly used for therapy of uncomplicated UTIs. More than 75.0% of the most frequently isolated pathogens from UTIs, except for P. aeruginosa (31.8%) and Acinetobacter spp. (11.1%), were susceptible to fosfomycin trometamol. The results obtained in this study, together with the infrequency of side effects and its pharmacokinetic properties, indicate that fosfomycin trometamol may be a useful alternative for single-dose therapy of uncomplicated UTIs.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008835244

Download citation: RISBibTeXText

PMID: 9491838

DOI: 10.1179/joc.1997.9.6.394


Related references

In vitro activity of fosfomycin trometamol compared with six other oral antibiotics against pathogens isolated of uncomplicated lower urinary tract infections in women. Abstracts of the General Meeting of the American Society for Microbiology 99: 164, 1999

Fosfomycin trometamol: activity in vitro against urinary tract pathogens. Infection 18(Suppl. 2): S60-S64, 1990

Comparative in vitro activity of fosfomycin trometamol against urinary tract pathogens. Neu, H C And J D Williams (Ed ) New Trends in Urinary Tract Infections: The Single-Dose Therapy; Symposium, Rome, Italy, January 30-31, 1987 X+357p S Karger Ag: Basel, Switzerland Illus 242-249, 1988

Fosfomycin trometamol vs amoxycillin single dose multicenter study of urinary tract infections. Chemotherapy 36(Suppl. 1): 19-23, 1990

Fosfomycin trometamol versus amoxycillin--single-dose multicenter study of urinary tract infections. ChemoTherapy 36(Suppl. 1): 19-23, 1990

Fosfomycin trometamol versus netilmicin in pediatric urinary tract infections a randomized multicenter study. Neu, H C And J D Williams (Ed ) New Trends in Urinary Tract Infections: The Single-Dose Therapy; Symposium, Rome, Italy, January 30-31, 1987 X+357p S Karger Ag: Basel, Switzerland Illus 171-177, 1988

Trometamol salt of fosfomycin versus netilmicin: randomized multicenter study in children's lower urinary tract infections. European Urology 13(Suppl. 1): 119-121, 1987

Fosfomycin trometamol vs. norfloxacin in adult female lower urinary tract infections multicenter randomized double blind study. Neu, H C And J D Williams (Ed ) New Trends in Urinary Tract Infections: The Single-Dose Therapy; Symposium, Rome, Italy, January 30-31, 1987 X+357p S Karger Ag: Basel, Switzerland Illus 316-318, 1988

Fosfomycin trometamol versus amoxycillin single dose therapy multicenter study in adult lower uncomplicated urinary tract infections. Neu, H C And J D Williams (Ed ) New Trends in Urinary Tract Infections: The Single-Dose Therapy; Symposium, Rome, Italy, January 30-31, 1987 X+357p S Karger Ag: Basel, Switzerland Illus 185-190, 1988

In vitro activity of fosfomycin trometamol in the treatment of Escherichia coli related uncomplicated urinary tract infections. Mikrobiyoloji Bulteni 43(4): 645-649, 2009

Urinary tract infections in pregnancy fosfomycin trometamol single dose treatment versus conventional therapy with pipemidic acid a multicenter study. Neu, H C And J D Williams (Ed ) New Trends in Urinary Tract Infections: The Single-Dose Therapy; Symposium, Rome, Italy, January 30-31, 1987 X+357p S Karger Ag: Basel, Switzerland Illus 197-206, 1988

In vitro testing of the antibacterial activity of fosfomycin trometamol against urinary pathogens. Chemioterapia 7(1): 10-14, 1988

Single-dose fosfomycin trometamol (Monuril) versus multiple-dose norfloxacin: results of a multicenter study in females with uncomplicated lower urinary tract infections. Urologia Internationalis 46(4): 344-348, 1991

Efficacy and safety of fosfomycin trometamol in the treatment of uncomplicated urinary tract infection interim report of a multicenter study. Neu, H C And J D Williams (Ed ) New Trends in Urinary Tract Infections: The Single-Dose Therapy; Symposium, Rome, Italy, January 30-31, 1987 X+357p S Karger Ag: Basel, Switzerland Illus 312-315, 1988

General practitioner study fosfomycin trometamol vs amoxycillin clavulanate in acute urinary tract infections. Chemotherapy 36(Suppl. 1): 24-26, 1990